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Sunday, February 16, 2014 109areduce or abolish the propensity for store-overload induced Ca release (SOICR)
in HEK293 cells. In addition, single channel analysis showed that these muta-
tions significantly reduce the response of the channel to activation by cytosolic
and luminal Ca. These observations demonstrate, for the first time, that sup-
pressed or loss of RyR2 function may be a common mechanism underlying
idiopathic ventricular fibrillation, which is opposite to the gain-of-function
RyR2 mutations associated with CPVT. Thus, understanding the exact molec-
ular defects of disease-causing RyR2 mutations will help to develop novel
approaches to the diagnosis and personalized treatment of these lethal cardiac
arrhythmias (Supported by CFI, CIHR, AIHS, and LCIA).
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Spontaneous sarcoplasmic reticulum (SR) Ca2þ release in the form of Ca2þ
waves occurs in cardiac cells under conditions of SR Ca2þ overload. This
store-overload induced Ca2þ release (SOICR) is a well-known cause of delayed
afterdepolarization and triggered arrhythmias. Hence, inhibiting SOICR may
represent a promising therapeutic strategy for Ca2þ-triggered arrhythmias.
Indeed, we have recently shown that carvedilol, one of the most effective
beta-blockers for preventing ventricular tachyarrhythmias and sudden death
in heart failure, possesses a novel anti-SOICR activity. To identify more
SOICR inhibitors, we searched the DrugBank database (http://www.
drugbank.ca) for chemicals with structures similar to carvedilol. We selected
a number of hit compounds and assessed their impact on SOICR in HEK293
cells expressing a SOICR-promoting cardiac ryanodine receptor (RyR2) muta-
tion (R4496C). We found that curcumin and resveratrol (natural phenols) and
bevantolol (a beta blocker and a Ca2þ channel blocker) suppress SOICR in
HEK293 cells with IC50s of 6.750.3, 48.453.6, 64.7511.3mM, respectively.
On the other hand, gliclazide, diphenhydramine, crocin, dexrazoxane, and
trazodone displayed little or no SOICR inhibition. We also tested several other
known cardioprotective drugs. We found that docosahexaenoic acid (DHA),
eicosapentaenoic (EPA), arachidonic acid (AA), anandamide, and a novel
derivative of anandamide (CS-X-95) inhibit SOICR in HEK293 cells with
IC50s of 11.254.2, 5.150.5, 5.550.9, 14.755.1, and 11.550.7 mM, respec-
tively, whereas ranolazine and S107 have no significant impact on SOICR.
These observations indicate that many cardioprotective drugs exhibit
anti-SOICR activity, and that SOICR inhibition may contribute, in part, to their
cardioprotective effect. (Supported by NIH)
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Skeletal muscle ryanodine receptor (RyR1) is a Ca2þ release channel in the
sarcoplasmic reticulum membrane and plays a key role in excitation-
contraction coupling. Obtaining high-resolution 3D structure of RyR1 is a
formidable challenge due to its enormous size (~2.3 MDa), dynamic nature
and location in the lipid membrane in native state. Detergents are traditionally
used to make membrane proteins water soluble and suitable for single-particle
cryo-EM. However, detergents tend to destabilize and inactivate membrane
proteins. In addition, the presence of detergent in the protein sample reduces
surface tension of water making it difficult to control the ice thickness and dis-
tribution of channel particles in cryospecimen, and leads to low-contrast in
cryo-images. To overcome these difficulties we used amphipathic polymer, am-
phipol 8-35 (APol8-35), to substitute for detergent in RyR1 preparations. We
tested functionality of RyR1/APol8-35 in a [3H]ryanodine binding assay, which
yielded Kd and Bmax values similar to those of the purified RyR1 in the presence
of CHAPS, indicating that the high-affinity binding site for ryanodine is re-
tained in RyR1/APol8-35. The use of Apol8-35 allowed us to reproducibly
obtain ice-embedded specimens of RyR1 for cryo-EM analysis and resulted
in improved ice thickness with channel particles uniformly distributed across
the holes in the grids. The protein contrast of ice-embedded RyR1/APol8-35
is substantially higher than in detergent preparations using a traditional CCDdetector. Furthermore, low-dose images of vitrified RyR1/APol8-35 have
been collected on the DE-12 back-thinned DDD camera using JEM3200FSC
electron cryomicrosope operated at 300 keV at liquid nitrogen temperature.
Preliminary analysis of these cryo-EM images demonstrates image
signals that extend beyond ~6A˚. Optimal conditions for both sample
vitrification and data acquisition were reached in order to achieve a higher res-
olution RyR1 structure. Supported by NIH (R21AR063255, R01GM072804,
R01GM080139, P41GM103832) and AHA (12GRNT10510002).
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A functional hallmark of inositol 1,4,5-trisphosphate receptors (IP3Rs), the
main Ca2þ release channels in the endoplasmic reticulum of virtually all
eukaryotic cells, is the coupled interplay between the binding of primary
ligands, IP3 and Ca
2þ, and channel gating. IP3Rs are exceptionally large
integral membrane proteins, comprising four subunits of over 300 kDa each.
A central mechanistic question of IP3R function is how IP3 binding in the
N-terminal sequence of the channel protein is communicated to the ion-
conduction pore, which is formed close to the C-terminus. Using single-
particle cryo-EM, we have performed structural analysis of purified tetrameric
IP3R1 vitrified in the presence of micromolar Ca
2þ and saturating concentra-
tion of adenophostin A (AdA), a structural mimetic of IP3, that is a high-
affinity, full agonist of IP3Rs. Cryo-EM images of IP3R1 were recorded on a
Gatan 4k x 4k CCD camera in the JEM2010F cryomicroscope operated at
low-dose conditions. Using EMAN2, ~40,000 particle images were merged
to generate a preliminary 3D map of ligand-bound IP3R1 at ~15 A˚ resolution.
A comparison with our recent structure of IP3R1, determined without the addi-
tion of any channel ligands (Ludtke et al., 2010: Structure 19, 1192-99), reveals
structural rearrangements in the cytoplasmic domains of the ligand-bound
IP3R1 channel. Furthermore, we have performed docking studies of available
crystal structures of the ligand-binding domains into reconstructed cryo-EM
density maps of the entire IP3R1. All together our studies suggest that AdA/
Ca2þ binding induces conformational changes in the quaternary structure of
tetrameric IP3R1 that might underlie the long-range allosteric mechanism
of agonist-mediated activation of the ion-conducting pore of IP3R. Supported
by grants from NIH (R21AR063255, R01GM072804, R01GM080139,
P41GM103832) and by AHA (12GRNT10510002).
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We studied the synchronous function (coupled gating) of arrays of striated
muscle ryanodine receptors (RyRs) reconstituted into planar bilayers. We think
that understanding coupled gating would help explain local Ca2þ sparks and
global Ca2þ transients which arise from the simultaneous activation of groups
of RyRs in the sarcoplasmic reticulum. We have previously found that coupled
gating of multiple cardiac or skeletal RyRs requires luminal Ca2þ as current
carrier. In principle, this would suggest that Ca2þ flowing from the open
pore of a RyR, could activate neighboring channels (local CICR). However,
further analysis showed that coupled events are insensitive to changes in the
magnitude of lumen-to-cytosol Ca2þ flux. This is not compatible with the
idea of individual channels modulated by local CICR. As an alternative, we
tested the involvement of physical RyR-RyR interactions in the process of
coupled gating. We found that coupled gating of RyRs reconstituted in planar
bilayers is not significantly affected by agents that disrupt cytoskeletal
networks, FKBPs and/or kinases/phosphatases. However, the polycationic
amine spermine interfered with coupled RyR gating (suggesting a role for
electrostatic interactions). Additionally ryanodol, known to lock open channels
in a sub-conductance state, also affected coupled RyRs. Nevertheless, event
termination (synchronous channel closures) occurred even during ryanodol
substates. This was unexpected because single channels do not transition
from the ryanodol/ryanodine substate to the closed state. Overall, our results
suggest that modulation of coupled RyRs is different from that expected for
individual channels interacting by local CICR. We think that luminal Ca2þ pro-
motes conformational changes in RyRs allowing for cytosolic RyR-RyR
110a Sunday, February 16, 2014interactions of electrostatic nature that induce coupled events (Supported by
NIH R01 GM078665 and AHA-MWA 12180038).
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Maurocalcine (MCa) is a 33-amino acid peptide isolated from the venom of
Scorpio maurus palmatus, a Tunisian scorpion. It possesses efficient cell pene-
tration properties and has been shown to strongly modify ryanodine receptor
(RyR1) channel behavior by increasing open probability and inducing a
long-lasting subconductance state. The amino acid residue threonine at position
26 belongs to a putative phosphorylation site within MCa sequence. We inves-
tigated the effect of a) T26 phosphorylation (MCa T26Phospho) by protein
kinase A and b) replacement of T26 by glutamic acid residue to mimic phos-
phorylation on the effect of MCa on RyR1 properties. Using [3H]ryanodine
([3H]Ry) binding and single channel voltage-clamp measurements, we show
that both MCa T26Phospho and MCa T26E analogs almost completely lose
the ability to induce RyR1 activation. Neither MCa T26Phospho nor MCa
T26E (up to 2mM) increase [3H]rya binding. Small increase (~1.65-fold activa-
tion; p<0.01) was observed with high concentrations (10mM) of either MCa
T26Phospho or MCa T26E. Single channel measurements revealed that neither
MCa T26E nor MCa T26Phospho (up to 2mM) were able to induce the charac-
teristic long-lasting subconductance state of RyR1 observed in presence of
wild-type MCa. MCa T26Phospho altered RyR1 channel gating in a time-
dependent biphasic manner with initial activation of Po followed by almost
complete inactivation. These effects of MCa T26Phospho could be reversed
by 200nM wt MCa. At concentrations R2mM, MCa T26E enhances Po~3
fold by shortening tc without altering to. These results show that single
phosphorylation of MCa modifies RyR1 activity.1P01 AR52354.
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Type 1 ryanodine receptor (RyR1) is a Ca2þ release channel in the sarco-
plasmic reticulum and plays a pivotal role in excitation-contraction coupling
in skeletal muscle. RyR1 is the major target for muscle diseases, e.g., malignant
hyperthermia (MH) and central core disease (CCD). To date, over 200 muta-
tions have been identified in the RyR1 gene of MH and CCD patients. It is
widely believed that MH and CCD mutations cause hyperactivation of the
Ca2þ-induced Ca2þ release (CICR), resulting in abnormal Ca2þ homeostasis
in skeletal muscle. CICR shows biphasic Ca2þ dependence, thus the activity
can be determined by three parameters: sensitivity to activating Ca2þ, sensi-
tivity to inactivating Ca2þ, and the gain (i.e., peak activity). However, it
remains unclear how the disease-associated mutations affects these parameters.
In this study, we expressed several RyR1 channels carrying different MH/CCD
mutations at amino-terminal region in HEK cells and tested their CICR by
live-cell Ca2þ imaging and [3H]ryanodine binding. Our results suggest that
the amino-terminal disease-associated mutations divergently affects the param-
eters of CICR depending on the sites for mutation. The underlying molecular
mechanism will be discussed.
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Ryanodine receptors, located in the sarcoplasmic/endoplasmic reticulum
(SR/ER) membrane, are required for intracellular Ca2þ release that is involved
in a wide range of cellular functions. Malignant hyperthermia (MH) is a phar-
macogenetical complication of general anesthesia resulting from abnormalCa2þ-induced Ca2þ release (CICR) via the type 1 ryanodine receptor (RyR1)
in skeletal muscles. The typical symptoms include a rapid increase in body
temperature and induction of a hypermetabolic state with skeletal muscle rigid-
ity. More than 200 mutations in the RyR1 gene have been reported in MH
patients. Most of those mutations have been found in three ‘‘hot spots’’ regions
of RyR1. However, there were only a few experimental results confirming
those mutations being responsible for the increment of the CICR sensitivities.
We improved the method for making MH mutants in the cDNA of RyR1. We
characterized the functional mutations on RyR1 in non-muscle cells, specif-
ically HEK293 cells with tetracycline-regulated RyR1 expression. Rabbit
RyR1 channels carrying corresponding mutations were expressed in HEK293
cells for functional assay. HEK293 cells were loaded at room temperature
with fura-2 AM in physiological salt solution. Fluorescence images were
acquired using an inverted microscope equipped with a objective, a cooled
CCD camera and a polychromatic illumination system. We characterized the
functional mutations on RyR1 in HEK293 cells. It was found that disease-
associated mutations of the RyR1 resulted in enhanced Ca2þ release activity,
therefore these mutations would be responsible for the MH incidence. These
results suggest that exploration of the functional mutations of RyR1 is probably
effective in preventive diagnosis of patients associated with MH disease.
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Skeletal and cardiac ryanodine receptors (RyRs) are ~65% similar in their
primary sequences, though differences in their regulation by physiological mol-
ecules have been observed. Skeletal RyR (RyR1) is inhibited by millimolar
Ca2þ with ~10 fold higher affinity than cardiac isoform (RyR2). Using
RyR1/RyR2 chimera channels and [3H]ryanodine binding measurements, we
found that two distinct regions are involved in isoform-specific Ca2þ-depen-
dent inactivation. One region includes two EF hand Ca2þ binding motifs
(RyR1 amino acids 4081-4092 and 4116-4127) and the other contains the sec-
ond transmembrane segment (S2). The results suggest a possible cytoplasmic
domain interaction between these two regions (or involving the flanking
regions of S2). Human disease associated mutations have been identified in
S2-S3 cytoplasmic loop of RyR1. We found that G4733E and R4736W malig-
nant hyperthermia associated mutations reduced affinity for Ca2þ dependent
inactivation of the channels by 5-6 fold (IC50: 6.750.6 mM (G4733E) and
5.550.2 mM (R4736W) vs 1.150.1 mM (wild type RyR1)), whereas muta-
tions in S4-S5 cytoplasmic loop (T4825I and H4832Y) reduced affinity by
2-3 fold. We also found that the activities of G4733E- and R4736W-RyR1 mu-
tants are suppressed at 10-100 mMCa2þ, and the suppressions are relieved by 1
mMMg2þ, which was observed in recombinant wild type RyR2 (Chugun et al.,
(2007) Am. J. Physiol. Cell Physiol.292, C535) but not in wild type RyR1.
Taken together, G4733E and R4736W mutations in S2-S3 loop confer
RyR2-type Ca2þ dependent inactivation and Mg2þ activation on RyR1. The
S2-S3 cytoplasmic loop may play a key role for domain interaction involved
in isoform-specific Ca2þ-dependent inactivation of RyRs. Supported by NIH
(R03AR061030), AHA (10SDG3500001), and NSF (EPS0903795).
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The ryanodine receptor (RyR) is an ion channel involved in the release of Ca2þ
from intracellular stores (sarcoplasmic reticulum) in muscle cells. RyR plays a
pivotal role in excitation-contraction coupling and is modulated by several
accessory proteins in vivo, including the immunophilin FK506 binding protein
12 (FKBP12) which, our previous studies demonstrate, binds to RyR with
extremely high affinity. The FKBP12 binding site within the RyR sequence
has not been definitively identified and a number of candidate regions have
been proposed. A central domain phosphorylation region of RyR (CDR) has
been crystallised (Sharma, P. et al, FEBS (2013)288, 903-914; Yuchi, Z.
et al., Structure (2012) 20, 1210-1211). This domain has considerable sequence
and structural homology to its repeat region at the N-terminus (NTR) and a
pseudo atomic model of the two repeat regions, docked onto a topology model
of RyR, positions NTR adjacent to the previously proposed FKBP12 binding
domain and suggests a potential interaction (Zhu, L. et al, JBC (2013) 288,
903-914). The RyR1 interaction with FKBP12 was tested using [3H]ryanodine
binding to measure the Po of the channel of solubilised pig RyR preparations
and microsomal preparations. A dose response to FKBP12 reduced activity
